MedTrace Logo

Sarcopenia And Balance In Postmenopausal Osteoporosis

NCT03832088 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2019-02-21

No results posted yet for this study

Summary

The study was performed on 53 postmenopausal osteoporosis patients who presented to our osteoporosis outpatient clinic. Following written informed consent, patients were evaluated for sarcopenia according to the sarcopenia algorithm proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Algorithm parameters were walking speed, muscle strength and muscle mass measurements. We used Timed Up and Go Test (TUG) for evaluation of walking speed, Jamar Hand Dynamometer for muscle strength assessment, and calf circumference for muscle mass measurement. Balances of the patients were evaluated with Berg Balance Scale (BBS) and functional skills were evaluated with the Timed Up and Go Test (TUG). Other clinical parameters (age, body mass index (BMI), 25OHvitD level, menopause age, fall within the last year, fracture history, history of fracture in mother) were questioned.

Conditions

  • Osteoporosis, Postmenopausal
  • Balance; Distorted
  • Sarcopenia

Interventions

DIAGNOSTIC_TEST

Berg Balance Scale

Berg Balance Scale performed for balance disorder

DIAGNOSTIC_TEST

Timed Up and Go Test

Timed Up and Go Test for walking speed

DIAGNOSTIC_TEST

Jamar hand dynamometer

Jamar hand dynamometer for grip strength which correlates with muscle strength of patient

DIAGNOSTIC_TEST

Calf circumference

Calf circumference for muscle mass evaluation. Calf circumference is an anthropometric measurement which correlates with muscle mass.

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03832088 on ClinicalTrials.gov